Adverse drug reactions in patients with phaeochromocytoma: Incidence, prevention and management

Medicine & Life Sciences

• Pheochromocytoma 100%
• Drug-Related Side Effects and Adverse Reactions 83%
• Catecholamines 50%
• Incidence 43%
• Pharmaceutical Preparations 37%
• veralipride 35%
• Dopamine D2 Receptor Antagonists 25%
• Ephedrine 24%
• Sympathomimetics 23%
• Neoplasms 23%
• Metoclopramide 22%
• Monoamine Oxidase Inhibitors 22%
• Adrenergic Antagonists 22%
• Peptide Hormones 21%
• Tricyclic Antidepressive Agents 21%
• Neuroendocrine Tumors 20%
• Glucagon 18%
• Adrenocorticotropic Hormone 17%
• Adrenergic Receptors 17%
• Glucocorticoids 16%
• Adrenal Cortex Hormones 14%
• Anesthesia 14%
• Hormones 12%
• Blood Pressure 11%
• Therapeutics 5%

Chemistry

• Drug 47%
• Catecholamine 41%
• Veralipride 39%
• Dopamine 2 Receptor Blocking Agent 31%
• Corticotropin 28%
• Metoclopramide 28%
• Tricyclic Antidepressant Agent 25%
• EC 1.4.3.4 (Monoamine Oxidase) Inhibitor 25%
• Glucagon 24%
• (-)-Ephedrine 23%
• Peptide Hormone 23%
• Glucocorticoid 23%
• Adrenal Cortex Hormone 23%
• Blood Pressure 22%
• Agent Interacting With Transmitter, Hormone or Drug Receptor 19%

Social Sciences

• incidence 76%
• drug 60%
• adverse events 48%
• management 42%
• blood pressure 22%
• disposition 16%
• manipulation 15%
• medication 15%
• clinician 15%
• vulnerability 14%
• evidence 7%